abstract |
The present invention relates to an in vitro diagnostic method for colorectal cancer by determining the presence of prodefensin-A6 in a biological sample obtained from a patient suspected of having colorectal cancer. The method can be used for early diagnosis, screening, follow-up treatment, prognosis and recurrence diagnosis for colorectal cancer. |